| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $26K | +11.7% | +32.3% |
| Cost of Revenue | $3K | +70.8% | — |
| R&D Expense | $2.6M | -15.1% | -39.9% |
| SG&A Expense | $2.3M | +25.2% | +21.3% |
| Operating Income | -$4.9M | +0.1% | +21.5% |
| Income Tax | $0 | — | — |
| Net Income | -$5.0M | -5.7% | +17.5% |
| EPS (Basic) | -$0.04 | +0.0% | +20.0% |
| EPS (Diluted) | -$0.04 | +0.0% | +20.0% |
| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $22.1M | -11.7% | -24.3% |
| Accounts Receivable | $11K | -42.7% | +33.3% |
| Current Assets | $22.8M | -10.9% | -24.1% |
| Total Assets | $32.4M | -9.0% | -18.5% |
| Current Liabilities | $1.1M | -28.6% | -26.4% |
| Total Liabilities | $3.6M |
| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.3M | -108.0% | — |
| Capital Expenditures | $894K | +4.7% | — |
| Investing Cash Flow | -$1.0M | -11.4% | — |
| Financing Cash Flow | $2.7M | +52.9% | — |
| Free Cash Flow | -$8.2M | -87.7% | — |
| -13.8% |
| Stockholders' Equity | $28.8M | -8.6% | -19.1% |